Biological Therapy Analysis & Statistics, November 2009 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

571-581 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

Competitor Analysis CXCR and CXCL Agonists and Antagonists

Competitor Analysis CXCR and CXCL Agonists and Antagonists

  • $ 396
  • Company report
  • November 2009
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about CXCR agonists and CXCR/CXCL antagonists provides a competitor evaluation in the field of chemokine receptor CXCR or its ligands CXCL ...

  • Industries : Pharmaceutical, Biological Therapy, Pathology
Immunotherapies and Vaccines for Nontraditional Indications

Immunotherapies and Vaccines for Nontraditional Indications

  • $ 2 995
  • Industry report
  • October 2009
  • by CHI Insight Pharma Reports

Novel applications of immunotherapies and vaccines beyond prevention and treatment of infectious diseases and cancer are reviewed. Those discussed typically target molecules not normally targeted by the ...

  • Industries : Pharmaceutical, Pathology
Therapeutic Monoclonal Antibodies Markets

Therapeutic Monoclonal Antibodies Markets

  • $ 1 999
  • Industry report
  • June 2009
  • by TriMark Publications

Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) ...

  • Industries : Biopharmaceutical, Pathology, Biotechnology, Pharmaceutical
  • Countries : United States
Monoclonal Antibodies in Cancer Therapy 2009-2024

Monoclonal Antibodies in Cancer Therapy 2009-2024

  • $ 2 323
  • Industry report
  • May 2009
  • by Visiongain

Report Details Monoclonal antibodies in cancer therapy – significant commercial opportunities with developing technologies and innovative products – our new report explains prospects Monoclonal antibody-based ...

  • Industries : Diagnostics, Diagnostics, Biopharmaceutical, In Vitro Diagnostic, In Vitro Diagnostic, Biotechnology, Biological Therapy
Competitor Analysis: Sphingosine-1-Phosphate (S1P)

Competitor Analysis: Sphingosine-1-Phosphate (S1P)

  • $ 132
  • Industry report
  • April 2009
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Sphingosine-1-Phosphate (S1P) provides a competitor evaluation in the field of molecules interacting with the sphingosine-1-phosphate ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Biological Therapy
Western European Market for Cardiac Rhythm Management

Western European Market for Cardiac Rhythm Management

  • $ 6 000
  • Industry report
  • January 2009
  • by Frost & Sullivan

The study attempts to spot trends, identify market dynamics and challenges and evaluate the market for the various equipment that have been classified as cardiac rhythm management devices for the treatment ...

  • Industries : Cardiovascular Devices, Healthcare, Building and Engineering, Medical Devices
  • Countries : Europe
Molecular Diagnostics: A Dynamic and Rapidly Broadening Market

Molecular Diagnostics: A Dynamic and Rapidly Broadening Market

  • $ 2 995
  • Industry report
  • January 2009
  • by CHI Insight Pharma Reports

Molecular diagnostic applications in the areas of oncology, personalized medicine, inherited disorders, prediction of genetic disease risk, and many others are rapidly increasing in number as this burgeoning ...

  • Industries : Pharmaceutical, Pathology, In Vitro Diagnostic, In Vitro Diagnostic, Diagnostics, Diagnostics, General Medicine and Specialty Medicine, Therapy, Genomics, Biological Therapy, Biotechnology
  • Countries : United States
RNA Interference Markets (Edition December 2008)

RNA Interference Markets (Edition December 2008)

  • $ 3 400
  • Industry report
  • December 2008
  • by TriMark Publications

Since its discovery, the naturally occurring RNA (ribonucleic acid) interference effect has been acclaimed as the most exciting technical breakthrough in biological research in the last decade. Some industry ...

  • Industries : Diagnostics, Diagnostics, Biotechnology, Biological Therapy
  • Countries : United States
Stem Cells Come of Age

Stem Cells Come of Age

  • $ 2 995
  • Industry report
  • November 2008
  • by CHI Insight Pharma Reports

Commercialization of stem cells can potentially help to treat an astounding variety of medical conditions. After a slow start, the stem cell age is finally poised to begin, as numerous factors converge ...

  • Industries : Pharmaceutical, Biological Therapy
  • Countries : United States
Immunotherapies and Vaccines for Cancer and Infectious Diseases Report

Immunotherapies and Vaccines for Cancer and Infectious Diseases Report

  • $ 2 995
  • Industry report
  • October 2008
  • by CHI Insight Pharma Reports

The field of therapeutic vaccines and immunotherapies is rapidly emerging as a promising area. Use of passive immunotherapy (i.e., antibody) products, for prevention of infection or for treatment of many ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
MicroRNAs: Commercial Products on the Horizon

MicroRNAs: Commercial Products on the Horizon

  • $ 2 995
  • Industry report
  • March 2008
  • by CHI Insight Pharma Reports

With the first diagnostics set to debut within a year, the new research and development field of microRNAs is beginning to reveal its potential. This new report establishes a baseline for observing microRNAs’ ...

  • Industries : Pharmaceutical, Genomics, Biotechnology, Biological Therapy
  • Countries : United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.